Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 231

1.

Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism.

Kahaly GJ, Riedl M, König J, Diana T, Schomburg L.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4333-4341. doi: 10.1210/jc.2017-01736.

PMID:
29092078
2.

Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.

Al-Majdoub M, Lantz M, Spégel P.

Thyroid. 2017 Sep;27(9):1109-1117. doi: 10.1089/thy.2017.0218. Epub 2017 Aug 18.

PMID:
28699427
3.

Impaired Metabolism of Selenomethionine in Graves' Disease: A Biokinetics Study of Soft Gel Capsule Formulation.

Duntas LH, Boutsiadis A, Tsakris A.

Horm Metab Res. 2017 Aug;49(8):589-594. doi: 10.1055/s-0043-113573. Epub 2017 Jul 5.

PMID:
28679141
4.

PREDICTION OF RELAPSE FROM HYPERTHYROIDISM FOLLOWING ANTITHYROID MEDICATION WITHDRAWAL USING TECHNETIUM THYROID UPTAKE SCANNING.

Nakhjavani M, Abdollahi S, Farzanefar S, Abousaidi M, Esteghamati A, Naseri M, Eftekhari M, Abbasi M.

Endocr Pract. 2017 Apr 2;23(4):466-470. doi: 10.4158/EP161523.OR.

PMID:
28437154
5.

MiR-346 and TRAb as Predicative Factors for Relapse in Graves' Disease Within One Year.

Li J, Cai Y, Sun X, Yao D, Xia J.

Horm Metab Res. 2017 Mar;49(3):180-184. doi: 10.1055/s-0043-100116. Epub 2017 Feb 13.

PMID:
28192819
6.

Double-blinded randomised placebo-controlled clinical trial of individualised homeopathic treatment of hyperthyroid cats.

Bodey AL, Almond CJ, Holmes MA.

Vet Rec. 2017 Apr 15;180(15):377. doi: 10.1136/vr.104007. Epub 2017 Jan 11.

PMID:
28077754
7.

Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines.

Yang H, Cong Y, Wu T, Tang H, Ma M, Zeng J, Zhang W, Lian Z, Yang X.

Pharm Biol. 2017 Dec;55(1):258-263.

PMID:
27927064
8.

Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Leo M, Bartalena L, Rotondo Dottore G, Piantanida E, Premoli P, Ionni I, Di Cera M, Masiello E, Sassi L, Tanda ML, Latrofa F, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2017 Mar;40(3):281-287. doi: 10.1007/s40618-016-0559-9. Epub 2016 Oct 12.

PMID:
27734319
9.

Monocyte and Basophil Counts as Predictors of Neutrophil Count Recovery in Patients with Thiamazole-Induced Agranulocytosis.

Onose H, Uchida T, Sato J, Ishii S, Yamada E, Yamada T, Watada H.

Exp Clin Endocrinol Diabetes. 2017 Jan;125(1):49-52. doi: 10.1055/s-0042-105281. Epub 2016 May 24.

PMID:
27219883
10.

Use of methimazole and risk of acute pancreatitis: A case-control study in Taiwan.

Lai SW, Lin CL, Liao KF.

Indian J Pharmacol. 2016 Mar-Apr;48(2):192-5. doi: 10.4103/0253-7613.178841.

11.

Does low-normal serum TSH level adversely impact cognition in elderly adults and might methimazole therapy improve outcomes?

Chachamovitz DS, Vigário Pdos S, Silva SO, Teixeira LB, Fagundes ML, Vaisman M, Teixeira Pde F.

Endocr J. 2016 May 31;63(5):495-505. doi: 10.1507/endocrj.EJ15-0458. Epub 2016 Apr 6.

12.

Methimazole discontinuation before radioiodine therapy in patients with Graves' disease.

Zakavi SR, Khazaei G, Sadeghi R, Ayati N, Davachi B, Bonakdaran S, Jabbari Nooghabi M, Moosavi Z.

Nucl Med Commun. 2015 Dec;36(12):1202-7. doi: 10.1097/MNM.0000000000000384.

PMID:
26426965
13.

Does low serum TSH within the normal range have negative impact on physical exercise capacity and quality of life of healthy elderly people?

Chachamovitz DS, Vigário Pdos S, Carvalho RC, Silvestre DH, Moerbeck AE, Soffientini MG, Luna ÉL, Rosemberg CW, Mainenti MR, Vaisman M, Teixeira Pde F.

Arch Endocrinol Metab. 2015 Jul 24;60(3):236-45. doi: 10.1590/2359-3997000000079.

14.

Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.

Kyrilli A, Tang BN, Huyge V, Blocklet D, Goldman S, Corvilain B, Moreno-Reyes R.

J Clin Endocrinol Metab. 2015 Jun;100(6):2261-7. doi: 10.1210/jc.2015-1026. Epub 2015 Apr 13.

PMID:
25867812
15.

A second course of antithyroid drug therapy for recurrent Graves' disease: an experience in endocrine practice.

Liu X, Qiang W, Liu X, Liu L, Liu S, Gao A, Gao S, Shi B.

Eur J Endocrinol. 2015 Mar;172(3):321-6. doi: 10.1530/EJE-14-0704. Epub 2014 Dec 2.

16.

Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.

Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K, Nagataki S, Taniyama M.

Thyroid. 2015 Jan;25(1):43-50. doi: 10.1089/thy.2014.0084.

PMID:
25178068
17.

A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.

Liu X, Qiang W, Liu X, Liu L, Liu S, Gao A, Gao S, Shi B.

Exp Clin Endocrinol Diabetes. 2014 Nov;122(10):564-7. doi: 10.1055/s-0034-1377045. Epub 2014 Aug 20.

PMID:
25140995
18.

[Peripheral blood cell factors of Graves ophthalmopathy and effect of intervention with tripterygium glycosides].

Xu JP, Xu JP, Xu C, Chen J, Jin ZH, Zheng HF, Zhu J.

Zhongguo Zhong Yao Za Zhi. 2014 Feb;39(3):544-7. Chinese.

PMID:
24946565
19.

The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats.

Hill KE, Gieseg MA, Bridges J, Chambers JP.

N Z Vet J. 2014 Jul;62(4):208-13. doi: 10.1080/00480169.2013.875990. Epub 2014 Feb 28.

PMID:
24350893
20.

Efficacy and safety of methimazole ointment for patients with hyperthyroidism.

Wu X, Liu H, Zhu X, Shen J, Shi Y, Liu Z, Gu M, Song Z.

Environ Toxicol Pharmacol. 2013 Nov;36(3):1109-12. doi: 10.1016/j.etap.2013.09.015. Epub 2013 Sep 29.

PMID:
24148291

Supplemental Content

Loading ...
Support Center